Please Wait.....
Report
Point-of-Care Molecular Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-07-02 I 131 Pages I Mordor Intelligence
Point-of-Care Molecular Diagnostics Market Analysis
The point of care molecular diagnostics market is valued at USD 3.98 billion in 2025 and is projected to reach USD 6.08 billion in 2030, reflecting an 8.77% CAGR over 2025-2030. This solid upward path underscores an industry-wide transition from centralized laboratories to compact platforms that deliver polymerase chain reaction-grade sensitivity in less than 30 minutes at the bedside. Growth drivers include the widening menu of respiratory, gastrointestinal, sexually transmitted, and oncology assays, strong public investment in diagnostic resilience, and the rapid integration of cloud-based data management that allows clinicians to retrieve, interpret, and archive results almost instantly.
North America remains the largest regional contributor, benefitting from an extensive installed base, early regulatory approvals, and relatively predictable payer frameworks, while Asia Pacific is emerging as the volume engine as China and India invest in decentralized testing to support antimicrobial stewardship and precision oncology. Competitive intensity is building as incumbents miniaturize thermal cyclers, newcomers commercialize isothermal systems that omit temperature cycling, and both groups deploy software dashboards that knit scattered devices into unified diagnostic networks. Even so, reimbursement ambiguity, the rising cost of regulatory compliance for laboratory-developed tests, and gaps in cold-chain infrastructure for reagent distribution threaten to slow uptake in certain settings, particularly tropical or resource-constrained regions that stand to benefit most.
Global Point-of-Care Molecular Diagnostics Market Trends and Insights
Increased Demand for Decentralized and Rapid Respiratory Infection Testing
Widespread clinical adoption of sub-20-minute respiratory panels has trimmed emergency department wait times, reduced empiric drug use, and limited unnecessary admissions. Health systems report that point-of-care molecular results shift therapeutic plans in the majority of encounters, which improves antimicrobial stewardship and shortens length of stay. Connectivity modules use HL7 or FHIR to push data into electronic health records, giving infection-control teams near real-time visibility that previously arrived hours later. These clear operational wins fuel high cartridge volumes during influenza and coronavirus seasons, which in turn secure stable recurring revenue for manufacturers within the point of care molecular diagnostics market.
Government and Programmatic Support for POC Molecular Diagnostics Adoption
The National Institutes of Health Point-of-Care Technologies Research Network opened six targeted funding calls in 2024, accelerating prototype development across oncology, infectious disease, and chronic condition monitoring. The U.S. Food and Drug Administration granted the first point-of-care hepatitis C RNA authorization in June 2024, enabling same-visit diagnosis and treatment for millions of chronically infected Americans. Comparable initiatives in Europe and Japan allocate multi-year budgets for platform deployment to shore up health-system preparedness against future outbreaks. Predictable public-sector support signals a structural rather than episodic demand curve, which improves capital planning for firms competing in the point of care molecular diagnostics market.
Fragmented and Uncertain Reimbursement Landscapes
Coding frameworks designed for central laboratories do not always translate to near-patient platforms, leaving providers unsure of payment rates. The 2024 FDA decision to phase out enforcement discretion for laboratory-developed tests imposes fresh compliance and documentation costs just as vendors lobby payers for equitable reimbursement. Oncology and multi-cancer early detection panels face even greater uncertainty because coverage determinations lag behind regulatory clearances, slowing uptake despite evident clinical benefit.
Other drivers and restraints analyzed in the detailed report include:
Technological Advancements Enabling New Applications in Oncology and Antimicrobial Stewardship / Expansion of POC MDx into Non-Traditional Settings / Cold-Chain Gaps for Lyophilized Reagents in Tropical Low-Income Regions /
For complete list of drivers and restraints, kindly check the Table Of Contents.
List of Companies Covered in this Report:
Abbott Laboratories / Roche / Danaher / Thermo Fisher Scientific / bioMerieux / Siemens Healthineers / Beckton Dickinson / Hologic / QIAGEN / QuidelOrtho / Visby Medical Inc. / Orasure Technologies / Meridian Bioscience / Co-Diagnostics / Pfizer / T2 Biosystems / Genedrive plc / Binx Health, Inc. /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Demand for Decentralized and Rapid Respiratory Infection Testing
4.2.2 Government and Programmatic Support for POC Molecular Diagnostics Adoption
4.2.3 Technological Advancements Enabling New Applications (e.g., Oncology, Antimicrobial Stewardship)
4.2.4 Expansion of POC MDx into Non-Traditional Settings (e.g., Physician Offices, Retail Pharmacies)
4.2.5 CLIA-waived Multiplex PCR Platforms Adoption in U.S. Physician Offices
4.2.6 Microfluidic Cartridge Innovation Catalyzing Oncology Gene Panels in Asia
4.3 Market Restraints
4.3.1 Fragmented and Uncertain Reimbursement Landscapes
4.3.2 High Regulatory and Transition Costs
4.3.3 Cold-Chain Gaps for Lyophilized Reagents in Tropical Low-Income Regions
4.3.4 Clinician Skepticism due to False-Positives in Isothermal NAAT
4.4 Regulatory Outlook
4.5 Technological Outlook
4.6 Porter's Five Forces Analysis
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitutes
4.6.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value/Volume)
5.1 By Product & Service
5.1.1 Assays & Kits
5.1.2 Instruments / Analyzers
5.1.3 Software & Digital Services
5.2 By Application
5.2.1 Infectious Diseases
5.2.2 Oncology
5.2.3 Hematology
5.2.4 Prenatal & Neonatal Testing
5.2.5 Endocrinology
5.2.6 Pharmacogenomics & Companion Dx
5.2.7 Other Applications
5.3 By Technology
5.3.1 PCR-based
5.3.2 INAAT
5.3.3 Other Technologies
5.4 By End User
5.4.1 Hospitals
5.4.2 Homecare Settings
5.4.3 Other End Users
5.5 By Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 South Korea
5.5.3.5 Australia
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 Competitive Landscape
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global level Overview, Market level overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and analysis of Recent Developments)
6.4.1 Abbott
6.4.2 F. Hoffmann-La Roche Ltd
6.4.3 Danaher
6.4.4 Thermo Fisher Scientific Inc.
6.4.5 BioMerieux SA
6.4.6 Siemens Healthineers AG
6.4.7 Becton, Dickinson and Company
6.4.8 Hologic Inc.
6.4.9 Qiagen N.V.
6.4.10 QuidelOrtho Corporation
6.4.11 Visby Medical Inc.
6.4.12 OraSure Technologies Inc.
6.4.13 Meridian Bioscience Inc.
6.4.14 Co-Diagnostics Inc.
6.4.15 Pfizer Inc.
6.4.16 T2 Biosystems Inc.
6.4.17 Genedrive plc
6.4.18 Binx Health, Inc.
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security